Dr. Blackwell is a leading industry consultant with broad experience that encompasses early process development to commercial operations. His product experience includes antibodies, vaccines,recombinant proteins, small molecules, peptides, cell therapy and medical devices. Clients include virtual start-ups to multinational pharma. Dr. Blackwell has regulatory experience with INDs, PAIs, DMFs, and leading NDA CMC submissions. He has extensive experience with CMO selection, oversight and management. He has been involved with third party Consent Decree monitoring, organizational mentoring, and quality system remediation. He has led or actively participated in more than forty product, company, or technology due diligence projects. Dr. Blackwell was on the formative management team and led Manufacturing and Technical Operations for Shore Therapeutics in the successful re-commercialization of Fenoglide.